La continua innovacin en esta clase de medicamentos y la expansin de sus indicaciones prometen mejorar an ms la salud de las personas con trastornos cardiometablicos
In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk
The money-back guarantee is also a nice touch
[3] Dietary modifications form the cornerstone of nausea management: Eat smaller, more frequent meals rather than three large meals daily Avoid high-fat, greasy, or heavily spiced foods that delay gastric emptying further Choose bland, easily digestible options such as toast, crackers, rice, or bananas during symptomatic periods Stay well hydrated with small, frequent sips of water or clear fluids Avoid lying down immediately after eating
Lippincott, Williams & Wilkins